HeartBeam, Inc.
BEATWNasdaqCIK 1779372HealthcareFiscal year ends Dec 31
Reports and events: 81 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1421:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-090241 |
| 2026-08-1320:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-089158 |
| 2026-08-1320:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349121 |
| 2026-08-0622:16 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-085822 |
| 2026-08-0320:15 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-084622 |
| 2026-07-0220:15 ET | 8-K | 3.01 Delisting notice | 0001213900-26-074979 |
| 2026-06-2421:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-071605 |
| 2026-06-2220:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-070628 |
| 2026-06-1821:00 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001193125-26-276053 |
| 2026-05-1320:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221565 |
| 2026-04-1620:48 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-044672 |
| 2026-03-1220:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104080 |
| 2025-11-2114:47 ET | 8-K | 8.01 Other events | 0001213900-25-113353 |
| 2025-11-1321:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280112 |
| 2025-08-1320:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-040135 |
| 2025-07-1618:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-064580 |
| 2025-05-2901:12 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001628280-25-028232 |
| 2025-05-1320:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-025064 |
| 2025-05-0514:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-039490 |
| 2025-04-2519:38 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-035509 |
| 2025-03-1320:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-012614 |
| 2025-02-2613:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-017245 |
| 2025-02-1801:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-014528 |
| 2024-11-0721:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-046250 |
| 2024-10-2300:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001628280-24-043338 |
| 2024-09-1014:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-039968 |
| 2024-08-1420:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-037202 |
| 2024-06-1801:19 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-053485 |
| 2024-05-0920:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001779372-24-000006 |
| 2024-05-0221:13 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001779372-24-000005 |
| 2024-04-3022:22 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0001779372-24-000004 |
| 2024-03-2020:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001779372-24-000002 |
| 2024-02-0523:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001779372-24-000001 |
| 2023-11-1421:02 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001779372-23-000034 |
| 2023-10-2520:01 ET | SC 13D | Ownership report, active investor | 0001193125-23-262975 |
| 2023-08-2820:26 ET | SC 13D | Ownership report, active investor | 0001493152-23-030364 |
| 2023-08-1020:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001779372-23-000021 |
| 2023-07-2612:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001779372-23-000019 |
| 2023-07-1120:31 ET | 8-K | 5.07 Shareholder vote results | 0001213900-23-056219 |
| 2023-06-0813:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001779372-23-000015 |
| 2023-06-0218:36 ET | SC 13D | Ownership report, active investor | 0001213900-23-045646 |
| 2023-05-2620:21 ET | DEF 14A | Proxy statementPeriod 2023-05-26 | 0001779372-23-000014 |
| 2023-05-2320:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001779372-23-000013 |
| 2023-05-1120:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001779372-23-000010 |
| 2023-05-0520:47 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-23-036932 |
| 2023-05-0312:38 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001779372-23-000009 |
| 2023-04-1712:51 ET | S-1/A | Registration statement, amended | 0001213900-23-030048 |
| 2023-04-1020:32 ET | S-1/A | Registration statement, amended | 0001213900-23-028604 |
| 2023-03-2422:16 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001779372-23-000007 |
| 2023-03-1620:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001779372-23-000006 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.